tiprankstipranks
Trending News
More News >
Aspen Group (ASPU)
:ASPU
US Market
Advertisement

Aspen Group (ASPU) AI Stock Analysis

Compare
373 Followers

Top Page

ASPU

Aspen Group

(OTC:ASPU)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
$0.00
▼(-100.00% Downside)
Aspen Group's overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. The company faces significant financial challenges, including persistent losses and cash flow issues. Technical analysis provides mixed signals, with potential bearish momentum and overbought conditions. The lack of earnings call data and corporate events means these factors do not influence the score.

Aspen Group (ASPU) vs. SPDR S&P 500 ETF (SPY)

Aspen Group Business Overview & Revenue Model

Company DescriptionAspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
How the Company Makes MoneyAspen Group generates revenue primarily through tuition and fees from its online degree programs. The company has a diverse range of offerings, including undergraduate and graduate programs in fields such as business, nursing, and education. Key revenue streams include enrollment fees, course materials, and other educational services. Additionally, Aspen Group may benefit from partnerships with employers or organizations that seek to provide educational opportunities to their employees. Marketing efforts targeting adult learners and partnerships with educational institutions also contribute to its revenue growth. The company's ability to maintain enrollment levels and expand its program offerings plays a crucial role in its financial success.

Aspen Group Earnings Call Summary

Earnings Call Date:Sep 17, 2025
(Q2-2024)
|
% Change Since: |
Next Earnings Date:Dec 16, 2025
Earnings Call Sentiment Positive
The earnings call reflects a positive sentiment with significant financial improvements, enrollment growth, and improved NCLEX pass rates despite revenue challenges and legal settlement costs.
Q2-2024 Updates
Positive Updates
Reduced Net Loss
Net loss narrowed by 30% year-over-year, demonstrating financial discipline and effective cost management.
Positive EBITDA
Achieved fourth consecutive quarter of positive EBITDA, with a cumulative positive EBITDA of approximately $2.7 million over the past four quarters.
Cash Generation and Liquidity
Generated over $400,000 of cash from operations and projected unrestricted cash balance exceeding $2 million by the end of January 2024.
Enrollment Growth
Enrollments increased by 5% year-over-year and 34% sequentially, reflecting strong demand for postgraduate nursing degrees.
Improved NCLEX Pass Rates
NCLEX first-time pass rate in Arizona increased to 89%, with similar success in Texas and Tennessee.
Cost Control Measures
Year-over-year G&A expense down 23% due to cost control efforts and restructuring in previous fiscal quarters.
Negative Updates
Revenue Decrease
Total revenue decreased by 19% year-over-year, mainly due to the teach-out of the pre-licensure program and lower marketing spend.
Legal Settlement Costs
Final settlement of $550,000 approved for class action complaint in Arizona, with $50,000 paid by Aspen University.
Heightened Cash Management Status
Aspen University remains on Heightened Cash Management 2 status, impacting the timing of federal financial aid reimbursements.
Company Guidance
During the Aspen Group's second quarter fiscal year 2024 earnings call, executives provided detailed guidance on the company's financial and operational performance. The company reported a notable 30% year-over-year reduction in net loss and achieved positive EBITDA for the fourth consecutive quarter. Enrollments rose by 34% sequentially, driven by strong demand in the healthcare sector, particularly for postgraduate nursing degrees. Despite a 19% decrease in total revenue to $13.8 million, attributed largely to the teach-out of the pre-licensure program, gross margin improved to 63%, up from 60% the previous year. The quarter saw a decrease in G&A expenses by 23% and a marked reduction in marketing spend, contributing to a positive cash flow from operations of $409,000. The company anticipates an unrestricted cash balance exceeding $2 million by the end of January 2024, bolstered by a significant financial aid payment of approximately $3.9 million. Additionally, Aspen University reported an 89% first-time NCLEX pass rate in Arizona, reflecting improved academic performance. However, the company withheld specific guidance for future quarters.

Aspen Group Financial Statement Overview

Summary
Aspen Group faces significant financial challenges across all verticals. The income statement shows persistent losses and inconsistent revenue growth, while the balance sheet highlights negative returns on equity. Cash flow issues further exacerbate the company's financial instability, suggesting a need for strategic improvements to achieve financial sustainability.
Income Statement
45
Neutral
Aspen Group's income statement shows a challenging financial position with declining revenues and negative net income over the years. The gross profit margin is relatively stable, but the net profit margin remains negative, indicating ongoing profitability issues. Revenue growth has been inconsistent, with a slight increase in the most recent year, but overall, the company struggles to maintain positive growth.
Balance Sheet
50
Neutral
The balance sheet reflects a moderate financial structure with a manageable debt-to-equity ratio. However, the return on equity is negative, highlighting the company's inability to generate profits from shareholders' equity. The equity ratio is reasonable, suggesting a balanced asset structure, but the overall financial health is weakened by persistent losses.
Cash Flow
40
Negative
Cash flow analysis reveals significant challenges, with negative free cash flow growth and a low operating cash flow to net income ratio. Although there is a slight improvement in free cash flow in the latest period, the overall cash flow position remains weak, indicating potential liquidity issues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue45.30M45.30M51.40M66.32M76.69M67.81M
Gross Profit30.06M30.06M31.44M35.53M41.44M38.36M
EBITDA2.94M2.94M-4.80M-1.85M-5.07M-5.94M
Net Income-1.54M-1.54M-13.58M-8.35M-9.59M-10.45M
Balance Sheet
Total Assets66.77M66.77M75.95M80.87M91.07M80.81M
Cash, Cash Equivalents and Short-Term Investments1.07M1.07M2.62M5.72M6.48M13.67M
Total Debt22.43M22.43M26.67M35.00M33.72M18.33M
Total Liabilities35.80M35.80M43.67M45.32M48.52M31.72M
Stockholders Equity30.97M30.97M32.28M35.55M42.55M49.09M
Cash Flow
Free Cash Flow233.72K233.72K-4.81M-7.00M-15.61M-7.99M
Operating Cash Flow1.19M1.19M-3.66M-4.40M-11.28M985.58K
Investing Cash Flow-1.02M-1.02M-1.33M-2.60M-4.33M-8.98M
Financing Cash Flow-1.72M-1.72M1.89M-190.47K14.86M3.75M

Aspen Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.08
Price Trends
50DMA
0.09
Negative
100DMA
0.08
Negative
200DMA
0.12
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
44.39
Neutral
STOCH
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPU, the sentiment is Negative. The current price of 0.08 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.09, and below the 200-day MA of 0.12, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 44.39 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASPU.

Aspen Group Risk Analysis

Aspen Group disclosed 64 risk factors in its most recent earnings report. Aspen Group reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aspen Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$1.82B15.806.89%3.16%4.31%-1.08%
$605.07M31.7510.20%5.50%338.59%
$3.56B15.8216.60%12.85%81.69%
$2.93B10.3023.04%17.25%30.15%
$20.33B14.63-3.31%3.23%1.93%-12.26%
$614.03M42.318.27%14.53%75.66%
$2.24M-11.86%85.16%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASPU
Aspen Group
0.09
0.07
350.00%
APEI
American Public Education
33.49
18.36
121.35%
ATGE
Adtalem Global Education
98.02
18.32
22.99%
LRN
Stride
68.04
-25.33
-27.13%
LINC
Lincoln Edu
19.42
5.87
43.32%
STRA
Strategic Education
75.98
-8.30
-9.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025